IgG against the Membrane-Proximal Portion of the Desmoglein 3 Ectodomain Induces Loss of Keratinocyte Adhesion, a Hallmark in Pemphigus Vulgaris.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 20 10 2021
revised: 18 07 2022
accepted: 25 07 2022
pubmed: 12 9 2022
medline: 25 1 2023
entrez: 11 9 2022
Statut: ppublish

Résumé

Pemphigus vulgaris is a severe autoimmune blistering disease characterized by IgG autoantibodies (auto-abs) against the desmosomal adhesion molecules desmoglein (DSG) 3 and DSG1. Underlying mechanisms leading to blister formation upon binding of DSG-specific IgG auto-abs are not fully understood. Numerous studies showed the pathogenicity of IgG auto-ab binding to the aminoterminal region 1 (EC1) of the DSG3 ectodomain. However, auto-abs in pemphigus vulgaris are polyclonal, including IgG against both aminoterminal- and membrane-proximal epitopes of the DSG3 ectodomain. In this study, the pathogenicity of a previously uncharacterized murine monoclonal IgG antibody, 2G4, directed against the membrane-proximal region (EC5) of the DSG3 ectodomain was characterized and tested in various specificity and functionality assays. The results clearly show that 2G4 is capable of inhibiting intercellular keratinocyte adhesion and of inducing cellular DSG3 redistribution by activation of the p38MAPK signal transduction pathway. In this study, we provide evidence that an IgG auto-abs directed against the membrane-proximal region EC5 of DSG3 induces acantholysis, the hallmark in pemphigus vulgaris. These findings challenge the current concept that IgG auto-abs targeting the NH

Identifiants

pubmed: 36089007
pii: S0022-202X(22)01901-7
doi: 10.1016/j.jid.2022.07.030
pii:
doi:

Substances chimiques

Desmoglein 3 0
Autoantibodies 0
Antibodies, Monoclonal 0
Immunoglobulin G 0
Desmoglein 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-263.e3

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Christoph Hudemann (C)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany. Electronic address: christoph.hudemann@staff.uni-marburg.de.

Yvonne Exner (Y)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany.

Robert Pollmann (R)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany.

Karina Schneider (K)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany.

Anna Zakrzewicz (A)

Institute of Biochemistry, Medical Faculty, Justus-Liebig-University Giessen, Giessen, Germany.

Simon Feldhoff (S)

Institute of Biochemistry, Medical Faculty, Justus-Liebig-University Giessen, Giessen, Germany.

Thomas Schmidt (T)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany.

Volker Spindler (V)

Institute of Anatomy and Cell Biology, Ludwig-Maximilians University Munich, Munich, Germany.

David Rafei-Shamsabadi (D)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany; Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany.

Frauke Völlner (F)

Institute of Biochemistry, Medical Faculty, Justus-Liebig-University Giessen, Giessen, Germany.

Jens Waschke (J)

Institute of Anatomy and Cell Biology, Ludwig-Maximilians University Munich, Munich, Germany.

Ritva Tikkanen (R)

Institute of Biochemistry, Medical Faculty, Justus-Liebig-University Giessen, Giessen, Germany.

Michael Hertl (M)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany.

Rüdiger Eming (R)

Department of Dermatology and Allergology, Philipps-University Marburg, Marburg, Germany; Department of Dermatology, Venerology and Allergology, German Armed Forces Central Hospital Koblenz, Koblenz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH